RDMD Revenue and Competitors

Location

$67.1M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • RDMD's estimated annual revenue is currently $3.2M per year.(i)
  • RDMD's estimated revenue per employee is $77,500
  • RDMD's total funding is $67.1M.

Employee Data

  • RDMD has 41 Employees.(i)
  • RDMD grew their employee count by -65% last year.

RDMD's People

NameTitleEmail/Phone
1
Head EngineeringReveal Email/Phone
2
Clinical Abstraction LeadReveal Email/Phone
3
Software EngineerReveal Email/Phone
4
Clinical Information AssociateReveal Email/Phone
5
Software EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is RDMD?

RDMD's mission is to empower patients and communities to accelerate the development of treatments for rare diseases of all kinds. We are a medical data science company that helps to identify patients and generate regulatory-grade evidence to enable drug approvals and real world evidence in rare disease. RDMD is privately funded by Lux Capital and Village Global, a venture capital firm with a network of LPs including Reid Hoffman, Bill Gates, Mark Zuckerberg, and Jeff Bezos. Read about our mission at www.rdmd.com

keywords:N/A

$67.1M

Total Funding

41

Number of Employees

$3.2M

Revenue (est)

-65%

Employee Growth %

N/A

Valuation

N/A

Accelerator

RDMD News

2020-04-18 - Daily funding roundup - April 17th, 2020

Gembah raised $3.3M; Learn In secured $3.5M; Everee picks up $10M; RDMD landed $14M Gembah: Gembah is a product development platform. Gembah has raised $3.3 million in seed funding led by Silverton Partners, with participation from ATX Venture Partners and Capital Factory. Read more. Learn In: ...

2020-04-16 - RDMD Secures $14M in Series A Financing

RDMD, a San Francisco, CA-based healthcare technology company focused on accelerating drug research for patients with rare diseases, raised $14m in Series A financing. The round was led by Spark Capital, with participation from existing seed investors Lux Capital, Village Global and Garuda Vent ...

2018-08-21 - Lux Capital Leads $3M Seed Funding for RDMD

SAN FRANCISCO--(BUSINESS WIRE)--RDMD, a healthcare technology company dedicated to accelerating research for patients with rare diseases, today announced that it has raised $3 million in seed financing. The financing was led by Lux Capital, with participation from Village Global, First Round's H ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.4M41-16%$100.3M
#2
$8.9M41-5%N/A
#3
$4.6M41N/AN/A
#4
$4.4M41-31%$2.8M
#5
$4.5M4171%$45.1M